Free Trial

Beauty Health (SKIN) Competitors

Beauty Health logo
$1.64 +0.04 (+2.17%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$1.56 -0.09 (-5.17%)
As of 05/30/2025 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SKIN vs. IRMD, EMBC, RXST, BBNX, CBLL, DCTH, AVNS, BFLY, BVS, and KIDS

Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include Iradimed (IRMD), Embecta (EMBC), RxSight (RXST), Beta Bionics (BBNX), CeriBell (CBLL), Delcath Systems (DCTH), Avanos Medical (AVNS), Butterfly Network (BFLY), Bioventus (BVS), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

Beauty Health vs.

Iradimed (NASDAQ:IRMD) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, community ranking, profitability, earnings, analyst recommendations, valuation and risk.

Iradimed has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.

Iradimed presently has a consensus target price of $72.00, indicating a potential upside of 23.92%. Beauty Health has a consensus target price of $1.42, indicating a potential downside of 13.88%. Given Iradimed's stronger consensus rating and higher possible upside, equities research analysts clearly believe Iradimed is more favorable than Beauty Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Iradimed
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Beauty Health
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

In the previous week, Beauty Health had 16 more articles in the media than Iradimed. MarketBeat recorded 22 mentions for Beauty Health and 6 mentions for Iradimed. Iradimed's average media sentiment score of 1.25 beat Beauty Health's score of 1.01 indicating that Iradimed is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Iradimed
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Beauty Health
15 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Iradimed has higher earnings, but lower revenue than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Iradimed$75.15M9.83$19.23M$1.5537.48
Beauty Health$322.47M0.64-$100.12M-$0.41-4.01

Iradimed received 221 more outperform votes than Beauty Health when rated by MarketBeat users. Likewise, 65.58% of users gave Iradimed an outperform vote while only 44.94% of users gave Beauty Health an outperform vote.

CompanyUnderperformOutperform
IradimedOutperform Votes
261
65.58%
Underperform Votes
137
34.42%
Beauty HealthOutperform Votes
40
44.94%
Underperform Votes
49
55.06%

Iradimed has a net margin of 26.26% compared to Beauty Health's net margin of -8.11%. Iradimed's return on equity of 24.12% beat Beauty Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Iradimed26.26% 24.12% 21.20%
Beauty Health -8.11%-44.83%-3.54%

92.3% of Iradimed shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 36.8% of Iradimed shares are held by company insiders. Comparatively, 41.0% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Iradimed beats Beauty Health on 14 of the 18 factors compared between the two stocks.

Get Beauty Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SKIN vs. The Competition

MetricBeauty HealthSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$202.85M$4.44B$5.42B$8.41B
Dividend YieldN/A45.22%5.28%4.17%
P/E Ratio-3.9229.1227.0519.79
Price / Sales0.6473.65406.30134.24
Price / CashN/A51.0838.2534.64
Price / Book3.435.706.744.50
Net Income-$100.12M$67.51M$3.23B$248.30M
7 Day Performance2.17%0.32%1.22%0.99%
1 Month Performance65.91%15.79%6.13%8.01%
1 Year Performance-25.57%14.59%25.25%8.86%

Beauty Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SKIN
Beauty Health
0.504 of 5 stars
$1.65
+2.2%
$1.42
-13.9%
-25.6%$202.85M$322.47M-3.921,030Trending News
IRMD
Iradimed
4.7202 of 5 stars
$54.21
+0.6%
$72.00
+32.8%
+36.8%$689.28M$75.15M36.14110News Coverage
Positive News
EMBC
Embecta
4.8332 of 5 stars
$11.62
-3.3%
$20.33
+75.0%
-14.1%$679.11M$1.08B11.621,900Positive News
Short Interest ↓
RXST
RxSight
3.0606 of 5 stars
$16.32
+15.0%
$37.90
+132.2%
-74.3%$663.20M$148.31M-19.66220Positive News
Gap Up
High Trading Volume
BBNX
Beta Bionics
N/A$15.10
+5.2%
$24.83
+64.5%
N/A$654.68M$69.83M0.00294News Coverage
Analyst Forecast
CBLL
CeriBell
2.7885 of 5 stars
$17.83
-0.8%
$32.50
+82.3%
N/A$644.43M$71.54M0.00N/APositive News
DCTH
Delcath Systems
3.6591 of 5 stars
$18.10
+5.8%
$22.75
+25.7%
+127.9%$630.35M$53.85M-13.4160News Coverage
Positive News
AVNS
Avanos Medical
2.1408 of 5 stars
$13.00
-0.8%
N/A-36.8%$601.17M$689.20M38.244,040Positive News
Analyst Revision
BFLY
Butterfly Network
2.1227 of 5 stars
$2.32
-1.3%
$4.00
+72.4%
+142.2%$573.71M$85.63M-5.04460Positive News
Gap Down
BVS
Bioventus
3.3282 of 5 stars
$6.93
+2.1%
$14.33
+106.8%
-2.2%$567.87M$567.70M-11.361,200Positive News
KIDS
OrthoPediatrics
4.7013 of 5 stars
$22.95
-0.5%
$35.83
+56.1%
-36.1%$557.39M$212.45M-18.66200Positive News

Related Companies and Tools


This page (NASDAQ:SKIN) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners
OSZAR »